FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1693434032> ?p ?o ?g. }

• W1693434032 endingPage "203" @default.
• W1693434032 startingPage "194" @default.
• W1693434032 abstract "Sorafenib, a multikinase inhibitor, has been used as an anti-angiogenic agent against highly vascular hepatocellular carcinoma (HCC) - yet associated with only moderate therapeutic effect and the high incidence of HCC recurrence. We have shown intratumoral hypoxia induced by sorafenib activated C-X-C receptor type 4 (CXCR4)/stromal-derived factor 1α (SDF1α) axis, resulting in polarization toward a tumor-promoting microenvironment and resistance to anti-angiogenic therapy in HCC. Herein, we formulated sorafenib in CXCR4-targeted lipid-coated poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) modified with a CXCR4 antagonist, AMD3100 to systemically deliver sorafenib into HCC and sensitize HCC to sorafenib treatment. We demonstrated that CXCR4-targeted NPs efficiently delivered sorafenib into HCCs and human umbilical vein endothelial cells (HUVECs) to achieve cytotoxicity and anti-angiogenic effect in vitro and in vivo. Despite the increased expression of SDF1α upon the persistent hypoxia induced by sorafenib-loaded CXCR4-targeted NPs, AMD3100 attached to the NPs can block CXCR4/SDF1α, leading to the reduced infiltration of tumor-associated macrophages, enhanced anti-angiogenic effect, a delay in tumor progression and increased overall survival in the orthotopic HCC model compared with other control groups. In conclusion, our results highlight the clinical potential of CXCR4-targeted NPs for delivering sorafenib and overcoming acquired drug resistance in liver cancer." @default.
• W1693434032 created "2016-06-24" @default.
• W1693434032 creator A5002973631 @default.
• W1693434032 creator A5030967316 @default.
• W1693434032 creator A5035577137 @default.
• W1693434032 creator A5052559632 @default.
• W1693434032 creator A5055818694 @default.
• W1693434032 creator A5077463854 @default.
• W1693434032 creator A5081275082 @default.
• W1693434032 creator A5090462767 @default.
• W1693434032 date "2015-10-01" @default.
• W1693434032 modified "2023-10-01" @default.
• W1693434032 title "CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer" @default.
• W1693434032 cites W1967974277 @default.
• W1693434032 cites W1971837077 @default.
• W1693434032 cites W1980466874 @default.
• W1693434032 cites W1984659376 @default.
• W1693434032 cites W1992112921 @default.
• W1693434032 cites W1994193851 @default.
• W1693434032 cites W2002516695 @default.
• W1693434032 cites W2003474213 @default.
• W1693434032 cites W2003773886 @default.
• W1693434032 cites W2006833192 @default.
• W1693434032 cites W2010976109 @default.
• W1693434032 cites W2013568031 @default.
• W1693434032 cites W2016828736 @default.
• W1693434032 cites W2020398834 @default.
• W1693434032 cites W2022293355 @default.
• W1693434032 cites W2022981155 @default.
• W1693434032 cites W2022996006 @default.
• W1693434032 cites W2023409962 @default.
• W1693434032 cites W2024903578 @default.
• W1693434032 cites W2031104374 @default.
• W1693434032 cites W2032760352 @default.
• W1693434032 cites W2044813154 @default.
• W1693434032 cites W2062063474 @default.
• W1693434032 cites W2066354221 @default.
• W1693434032 cites W2066685510 @default.
• W1693434032 cites W2066735451 @default.
• W1693434032 cites W2071501585 @default.
• W1693434032 cites W2075101140 @default.
• W1693434032 cites W2087020662 @default.
• W1693434032 cites W2087377825 @default.
• W1693434032 cites W2088629624 @default.
• W1693434032 cites W2094573329 @default.
• W1693434032 cites W2100102501 @default.
• W1693434032 cites W2106787323 @default.
• W1693434032 cites W2115034438 @default.
• W1693434032 cites W2131041162 @default.
• W1693434032 cites W2131783235 @default.
• W1693434032 cites W2148806906 @default.
• W1693434032 cites W2158303916 @default.
• W1693434032 cites W2162613747 @default.
• W1693434032 cites W2163382189 @default.
• W1693434032 doi "https://doi.org/10.1016/j.biomaterials.2015.07.035" @default.
• W1693434032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26218745" @default.
• W1693434032 hasPublicationYear "2015" @default.
• W1693434032 type Work @default.
• W1693434032 sameAs 1693434032 @default.
• W1693434032 citedByCount "100" @default.
• W1693434032 countsByYear W16934340322016 @default.
• W1693434032 countsByYear W16934340322017 @default.
• W1693434032 countsByYear W16934340322018 @default.
• W1693434032 countsByYear W16934340322019 @default.
• W1693434032 countsByYear W16934340322020 @default.
• W1693434032 countsByYear W16934340322021 @default.
• W1693434032 countsByYear W16934340322022 @default.
• W1693434032 countsByYear W16934340322023 @default.
• W1693434032 crossrefType "journal-article" @default.
• W1693434032 hasAuthorship W1693434032A5002973631 @default.
• W1693434032 hasAuthorship W1693434032A5030967316 @default.
• W1693434032 hasAuthorship W1693434032A5035577137 @default.
• W1693434032 hasAuthorship W1693434032A5052559632 @default.
• W1693434032 hasAuthorship W1693434032A5055818694 @default.
• W1693434032 hasAuthorship W1693434032A5077463854 @default.
• W1693434032 hasAuthorship W1693434032A5081275082 @default.
• W1693434032 hasAuthorship W1693434032A5090462767 @default.
• W1693434032 hasConcept C121608353 @default.
• W1693434032 hasConcept C126322002 @default.
• W1693434032 hasConcept C150903083 @default.
• W1693434032 hasConcept C207001950 @default.
• W1693434032 hasConcept C2776231280 @default.
• W1693434032 hasConcept C2778019345 @default.
• W1693434032 hasConcept C2778695046 @default.
• W1693434032 hasConcept C2780394083 @default.
• W1693434032 hasConcept C502942594 @default.
• W1693434032 hasConcept C71924100 @default.
• W1693434032 hasConcept C86803240 @default.
• W1693434032 hasConcept C96232424 @default.
• W1693434032 hasConcept C98274493 @default.
• W1693434032 hasConceptScore W1693434032C121608353 @default.
• W1693434032 hasConceptScore W1693434032C126322002 @default.
• W1693434032 hasConceptScore W1693434032C150903083 @default.
• W1693434032 hasConceptScore W1693434032C207001950 @default.
• W1693434032 hasConceptScore W1693434032C2776231280 @default.
• W1693434032 hasConceptScore W1693434032C2778019345 @default.
• W1693434032 hasConceptScore W1693434032C2778695046 @default.
• W1693434032 hasConceptScore W1693434032C2780394083 @default.

• next